InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: Blue Fin post# 380185

Tuesday, 10/26/2021 4:16:12 PM

Tuesday, October 26, 2021 4:16:12 PM

Post# of 402708
The Russian CRO subcontracted by the U.S. CRO is owned by one of Russian's largest Pharmaceutical companies. They have, in the past, collaborated with a Russian Sovereign Investment Fund.

Based on the havoc wreaked on the Russian population by Covid-19/Delta, IMO it is a reasonable (speculation) assumption that any gamesmanship by FDA/BP in the US coupled with efficacy demonstrated on the TOPLINE of Brilacidin's Clinical Trial...would drive IPIX into their open arms...where "approval" and "licensing" could be possibly done very quickly. (Russian Pharma/Russian Gov "Sovereign Fund" = expedited approval and exclusive licensing possibilities in Eastern Europe and Western Asia).

...all IMO...of course.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News